About Us
Hospira is a global company that supplies products to markets around the world.
By utilizing our expertise and broad capabilities, Hospira's One 2 One® business unit is a world leader in the contract manufacturing of parenteral products. Hospira's expertise comes from the successful manufacture of parenterals for nearly 70 years in a range of delivery systems, vials, flexible containers, cartridges and pre-filled syringes. This experience and focus on injectable drug product is made available to large and small bio/pharmaceutical companies through One 2 One® .The two companies, Hospira and its client, partner to take the new drug product to market and then efficiently manufacture the product for commercial supply.
One 2 One® can provide synergies, reduce redundancies and recognize true supply chain management cost savings for our customers.
- Vial filling and lyophilization in North America, Europe & Asia-Pacific
- Product development to meet multicompendial specifications
- Extensive expertise in worldwide regulatory requirements
- FDA registration of Europe and Asia-Pacific sites
- EMEA registration of U.S. and Asia-Pacific sites
- MHLW accreditation of U.S. and Australia sites
- Wide-ranging release testing capabilities at all sites
- On-site Qualified Persons
- Multi-language labeling and packaging capabilities
- Proficiency in cold-chain management

![]() |
Major Businesses/Products Hospira has a leading position in the manufacture and supply of a broad range of hospital products including:
|
European Contacts: +41 (0) 1926 835 554
Hospira One 2 One
275 North Field Drive
Lake Forest, IL 60045
UNITED STATES
Phone: 224-212-2267
Contact: One 2 One Global Pharmaceutical Services
- Pharmaceutical Contract Manufacturing
- Biopharmaceuticals Contract Manufacturing
- Biologics Manufacturing
- Lyophilization
- Sterile Filling
- Emulsion Manufacturing
- Cartridge Filling
- Syringe Filling
- Packaging and Labeling
- Product Development Services
- Flexible Containers
- Large Volume Parenterals
- Small Volume Parenterals
- Drug Delivery Systems
- Custom Diluents and Kitting
- Drug Development Research Impurity Identification and Qualification Services
- Contract Manufacturing: Recombinant Proteins And Peptides
- Hospira Announces FDA Approval Of Topotecan Injection
- Strategies For Pharmaceutical Development And Manufacturing
- Hospira Acquires EndoTool From MD Scientific
- Hospira Inks Deal With Genzyme
- Hospira Announces Plans To Integrate Symbiq And EndoTool Technologies
- Hospira Names Dr. Sumant Ramachandra Chief Scientific Officer
- Identification Of An Impurity In USP Lidocaine By A Novel High Resolution GC/MS Method And 1H NMR Spectroscopy
- Degradation Of Drug Product Caused By A Leak Detection Instrument: Mechanistic Studies Of Degradation
- Mechanistic Studies Of Degradant Formation For Two Pharmaceutically Active Steroid Succinate Compounds
- One 2 One Contract Manufacturing Capabilities
- Development And Validation Of A Quantitative Method For Six Residual Solvents In A Propylene Glycol Matrix By Gas Chromatography
- DURECT Signs POSIDURTM Manufacturing Agreement With Hospira
- Hospira Completes Acquisition Of Mayne Pharma, Announces New Commercial Leadership Structure
- Hospira Announces Collaborations To Interface Hospital Technologies And Improve Patient Safety
- Hospira Completes Acquisition Of Mayne Pharma, Announces New Commercial Leadership Structure
- Excellence In Medical Device Technologies Recognized At Frost & Sullivan Best Practices Awards Banquet


